Registration number:
E-Medical Revision Limited
for the Year Ended 31 August 2025
E-Medical Revision Limited
Contents
|
Company Information |
|
|
Balance Sheet |
|
|
Notes to the Unaudited Financial Statements |
E-Medical Revision Limited
Company Information
|
Directors |
Dr Nahida Bashir Dr Edward Alexander Smyth |
|
Registered office |
|
E-Medical Revision Limited
(Registration number: 08194992)
Balance Sheet as at 31 August 2025
|
Note |
2025 |
2024 |
|
|
Fixed assets |
|||
|
Tangible assets |
|
|
|
|
Investments |
|
|
|
|
|
|
||
|
Current assets |
|||
|
Debtors |
|
|
|
|
Cash at bank and in hand |
|
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net current assets |
|
|
|
|
Net assets |
|
|
|
|
Capital and reserves |
|||
|
Called up share capital |
|
|
|
|
Retained earnings |
|
|
|
|
Shareholders' funds |
|
|
For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.
Approved and authorised by the
|
......................................... |
|
......................................... |
E-Medical Revision Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025
|
Staff numbers |
The average number of persons employed by the company (including directors) during the year, was
E-Medical Revision Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)
|
Intangible assets |
|
Tangible assets |
|
Furniture, fittings and equipment |
Motor vehicles |
Total |
|
|
Cost or valuation |
|||
|
At 1 September 2024 |
|
|
|
|
Additions |
|
- |
|
|
At 31 August 2025 |
|
|
|
|
Depreciation |
|||
|
At 1 September 2024 |
|
|
|
|
Charge for the year |
|
|
|
|
At 31 August 2025 |
|
|
|
|
Carrying amount |
|||
|
At 31 August 2025 |
|
- |
|
|
At 31 August 2024 |
|
|
|
|
Investments |
|
2025 |
2024 |
|
|
Investments in associates |
|
|
|
Associates |
£ |
|
Cost |
|
|
At 1 September 2024 |
|
|
Additions |
|
|
At 31 August 2025 |
|
|
Provision |
|
|
Carrying amount |
|
|
At 31 August 2025 |
|
|
At 31 August 2024 |
|
E-Medical Revision Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)
|
4 |
Investments (continued) |
|
Debtors |
|
Current |
Note |
2025 |
2024 |
|
Amounts owed by related parties |
|
|
|
|
Prepayments |
|
|
|
|
|
|
|
Creditors |
Creditors: amounts falling due within one year
|
2025 |
2024 |
|
|
Due within one year |
||
|
Trade creditors |
- |
|
|
Taxation and social security |
|
|
|
Accruals and deferred income |
|
|
|
Other creditors |
|
|
|
|
|